Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lupin Limited ( (IN:LUPIN) ) has provided an update.
Lupin Limited has notified the Indian stock exchanges that it will hold its earnings call for the fourth quarter of fiscal year 2026 on Friday, May 8, 2026, at 16:00 IST via Zoom. The company has circulated an invitation link for investors and stakeholders to register for the call, underscoring its ongoing compliance with SEBI disclosure norms and its efforts to maintain transparent communication with the market on its financial performance.
More about Lupin Limited
Lupin Limited is an India-based pharmaceutical company engaged in the development, manufacture, and sale of generic and branded formulations, as well as active pharmaceutical ingredients. The company focuses on key therapeutic areas and serves regulated and emerging markets globally, with its equity shares listed on major Indian stock exchanges.
Average Trading Volume: 31,409
Technical Sentiment Signal: Buy
Current Market Cap: 1056.9B INR
Learn more about LUPIN stock on TipRanks’ Stock Analysis page.